Cargando…
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
Mutations in the genes encoding leucine-rich repeat kinase 2 (LRRK2) and α-synuclein are associated with both autosomal dominant and idiopathic forms of Parkinson’s disease (PD). α-Synuclein is the main protein in Lewy bodies, hallmark inclusions present in both sporadic and familial PD. We show tha...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611031/ https://www.ncbi.nlm.nih.gov/pubmed/23183827 http://dx.doi.org/10.1007/s00109-012-0984-y |
_version_ | 1782264527092449280 |
---|---|
author | Guerreiro, Patrícia Silva Huang, Yue Gysbers, Amanda Cheng, Danni Gai, Wei Ping Outeiro, Tiago Fleming Halliday, Glenda Margaret |
author_facet | Guerreiro, Patrícia Silva Huang, Yue Gysbers, Amanda Cheng, Danni Gai, Wei Ping Outeiro, Tiago Fleming Halliday, Glenda Margaret |
author_sort | Guerreiro, Patrícia Silva |
collection | PubMed |
description | Mutations in the genes encoding leucine-rich repeat kinase 2 (LRRK2) and α-synuclein are associated with both autosomal dominant and idiopathic forms of Parkinson’s disease (PD). α-Synuclein is the main protein in Lewy bodies, hallmark inclusions present in both sporadic and familial PD. We show that in PD brain tissue, the levels of LRRK2 are positively related to the increase in α-synuclein phosphorylation and aggregation in affected brain regions (amygdala and anterior cingulate cortex), but not in the unaffected visual cortex. In disease-affected regions, we show co-localization of these two proteins in neurons and Lewy body inclusions. Further, in vitro experiments show a molecular interaction between α-synuclein and LRRK2 under endogenous and over-expression conditions. In a cell culture model of α-synuclein inclusion formation, LRRK2 co-localizes with the α-synuclein inclusions, and knocking down LRRK2 increases the number of smaller inclusions. In addition to providing strong evidence for an interaction between LRRK2 and α-synuclein, our results shed light on the complex relationship between these two proteins in the brains of patients with PD and the underlying molecular mechanisms of the disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00109-012-0984-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3611031 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-36110312013-04-01 LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models Guerreiro, Patrícia Silva Huang, Yue Gysbers, Amanda Cheng, Danni Gai, Wei Ping Outeiro, Tiago Fleming Halliday, Glenda Margaret J Mol Med (Berl) Original Article Mutations in the genes encoding leucine-rich repeat kinase 2 (LRRK2) and α-synuclein are associated with both autosomal dominant and idiopathic forms of Parkinson’s disease (PD). α-Synuclein is the main protein in Lewy bodies, hallmark inclusions present in both sporadic and familial PD. We show that in PD brain tissue, the levels of LRRK2 are positively related to the increase in α-synuclein phosphorylation and aggregation in affected brain regions (amygdala and anterior cingulate cortex), but not in the unaffected visual cortex. In disease-affected regions, we show co-localization of these two proteins in neurons and Lewy body inclusions. Further, in vitro experiments show a molecular interaction between α-synuclein and LRRK2 under endogenous and over-expression conditions. In a cell culture model of α-synuclein inclusion formation, LRRK2 co-localizes with the α-synuclein inclusions, and knocking down LRRK2 increases the number of smaller inclusions. In addition to providing strong evidence for an interaction between LRRK2 and α-synuclein, our results shed light on the complex relationship between these two proteins in the brains of patients with PD and the underlying molecular mechanisms of the disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00109-012-0984-y) contains supplementary material, which is available to authorized users. Springer-Verlag 2012-11-27 2013-04 /pmc/articles/PMC3611031/ /pubmed/23183827 http://dx.doi.org/10.1007/s00109-012-0984-y Text en © Springer-Verlag Berlin Heidelberg 2012 |
spellingShingle | Original Article Guerreiro, Patrícia Silva Huang, Yue Gysbers, Amanda Cheng, Danni Gai, Wei Ping Outeiro, Tiago Fleming Halliday, Glenda Margaret LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models |
title | LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models |
title_full | LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models |
title_fullStr | LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models |
title_full_unstemmed | LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models |
title_short | LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models |
title_sort | lrrk2 interactions with α-synuclein in parkinson’s disease brains and in cell models |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611031/ https://www.ncbi.nlm.nih.gov/pubmed/23183827 http://dx.doi.org/10.1007/s00109-012-0984-y |
work_keys_str_mv | AT guerreiropatriciasilva lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels AT huangyue lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels AT gysbersamanda lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels AT chengdanni lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels AT gaiweiping lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels AT outeirotiagofleming lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels AT hallidayglendamargaret lrrk2interactionswithasynucleininparkinsonsdiseasebrainsandincellmodels |